GlassScriptPhysician profile
James W Cahill
NPI 1124183694
$25,867.29
in general payments reported to CMS, 2019-2025
34 companies · $5,203 in 2025
The $5,203 reported for 2025 was more than what 83% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,436 · 2020: $689 · 2021: $1,380 · 2022: $1,943 · 2023: $5,548 · 2024: $6,667 · 2025: $5,203.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $10K · Food and Beverage: $7,419.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $10,000.00 |
| Food and Beverage | $7,418.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $10,134.56 | 2023-2025 | Knee & Hip Implants Meniscal Repair Fiberstitch, Arthroplasty Implants Revers Total Shoulder Modular Glenoid Systems |
| Stryker Corporation | $8,523.04 | 2019-2025 | Mako, Insignia, Triathlon |
| Vericel Corporation | $1,938.50 | 2019 | |
| Seapearl East, INC | $1,810.37 | 2019-2025 | |
| Depuy Synthes Sales INC. | $608.42 | 2019-2025 | Monovisc, Symphony, Chia Percpasser |
| Zimmer Biomet Holdings, INC. | $403.71 | 2024-2025 | Identity, Mymobility Platform |
| Kerecis Limited | $402.76 | 2023-2025 | Kerecis Surgiclose, Kerecis Omega3 Surgiclose, Kerecis Graftguide |
| Davol INC. | $333.01 | 2024-2025 | Channel Drain, Surgiphor |
| Joint Restoration Foundation, INC. | $289.48 | 2019 | |
| Arthrosurface Incorporated | $245.24 | 2019 | |
| Exactech, INC. | $182.28 | 2023 | |
| Globus Medical, INC. | $131.83 | 2021-2025 | Excelsius Gps |
| Ferring Pharmaceuticals INC. | $114.06 | 2019-2025 | Euflexxa |
| Smith+Nephew, INC. | $104.15 | 2024-2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium, Bone Anchors With Arthroscopic Delivery System |
| Becton, Dickinson and Company | $101.02 | 2024 | Channel Drain |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heraeus Medical, LLC. | $72.91 | 2021-2025 | |
| Augmedics INC. | $58.80 | 2025 | Xvision |
| Sanara Medtech INC. | $50.86 | 2024 | Celleraterx |
| Kci USA, INC. | $45.90 | 2021-2022 | |
| Maxx Health INC | $37.21 | 2021 | |
| Bausch Health US, LLC | $35.11 | 2025 | Wellbutrin |
| Ossdsign USA Incorporated | $33.56 | 2025 | Ossdsign Catalyst |
| Bioventus LLC | $25.56 | 2025 | Bonescalpel & Sonicone (O.R.) |
| Ossur Americas, INC. | $22.83 | 2025 | Unloader One X |
| Zimvie INC. | $21.70 | 2022 | |
| Neos Therapeutics, LP | $17.95 | 2025 | Adzenys Xr-Odt |
| Fidia Pharma USA INC. | $17.86 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $17.65 | 2025 | Uzedy |
| Next Science LLC | $15.67 | 2021 | |
| Collegium Pharmaceutical, INC. | $15.66 | 2025 | Jornay Pm |
| Corium, LLC | $15.16 | 2025 | Azstarys |
| Pacira Therapeutics, INC. | $15.00 | 2021 | |
| Sanofi-Aventis U.S. LLC | $14.48 | 2019 | |
| Anika Therapeutics, INC. | $10.99 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Cahill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.